398 related articles for article (PubMed ID: 20861158)
1. In vivo imaging in cancer.
Condeelis J; Weissleder R
Cold Spring Harb Perspect Biol; 2010 Dec; 2(12):a003848. PubMed ID: 20861158
[TBL] [Abstract][Full Text] [Related]
2. Imaging metastatic cell trafficking at the cellular level in vivo with fluorescent proteins.
Hoffman RM
Methods Mol Biol; 2014; 1070():171-9. PubMed ID: 24092439
[TBL] [Abstract][Full Text] [Related]
3. [Development of fluorescent in vivo imaging probes for cancers].
Tanaka S; Kizaka-Kondoh S
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1272-6. PubMed ID: 18701836
[TBL] [Abstract][Full Text] [Related]
4. Advances in oncologic imaging: update on 5 common cancers.
Akin O; Brennan SB; Dershaw DD; Ginsberg MS; Gollub MJ; Schöder H; Panicek DM; Hricak H
CA Cancer J Clin; 2012; 62(6):364-93. PubMed ID: 23070605
[TBL] [Abstract][Full Text] [Related]
5. Photoacoustic imaging: a potential tool to detect early indicators of metastasis.
Bayer CL; Joshi PP; Emelianov SY
Expert Rev Med Devices; 2013 Jan; 10(1):125-34. PubMed ID: 23278229
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescence imaging of bone metastasis in rodents.
Snoeks TJ; van Beek E; Que I; Kaijzel EL; Löwik CW
Methods Mol Biol; 2012; 816():507-15. PubMed ID: 22130947
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of cancer: the basics.
Furlow B
Radiol Technol; 2003; 74(6):486-97; quiz 498-500. PubMed ID: 12908153
[No Abstract] [Full Text] [Related]
8. Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging.
Bauerle T; Komljenovic D; Semmler W
Curr Pharm Biotechnol; 2012 Mar; 13(4):584-94. PubMed ID: 22214500
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging: current applications and future directions.
Luker GD; Luker KE
J Nucl Med; 2008 Jan; 49(1):1-4. PubMed ID: 18077528
[TBL] [Abstract][Full Text] [Related]
10. Cyanine dyes in optical imaging of tumours.
Shi C; Zhang C; Su Y; Cheng T
Lancet Oncol; 2010 Sep; 11(9):815-6. PubMed ID: 20816373
[No Abstract] [Full Text] [Related]
11. MR - eyes for cancer: looking within an impenetrable disease.
Penet MF; Artemov D; Farahani K; Bhujwalla ZM
NMR Biomed; 2013 Jul; 26(7):745-55. PubMed ID: 23784955
[TBL] [Abstract][Full Text] [Related]
12. Visualization of single molecules of mRNA in situ.
Femino AM; Fogarty K; Lifshitz LM; Carrington W; Singer RH
Methods Enzymol; 2003; 361():245-304. PubMed ID: 12624916
[No Abstract] [Full Text] [Related]
13. Whole-body fluorescence imaging with green fluorescence protein.
Hoffman RM
Methods Mol Biol; 2002; 183():135-48. PubMed ID: 12136749
[No Abstract] [Full Text] [Related]
14. Diagnostic imaging in cancer.
Berman CG; Clark RA
Prim Care; 1992 Dec; 19(4):677-713. PubMed ID: 1465483
[TBL] [Abstract][Full Text] [Related]
15. Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use.
Hay R; Cao B; Tsarfaty I; Tsarfaty G; Resau J; Vande Woude G
J Cell Biochem Suppl; 2002; 39():184-93. PubMed ID: 12552618
[TBL] [Abstract][Full Text] [Related]
16. Options for visualizing metastatic disease in the living body.
Helms MW; Brandt BH; Contag CH
Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
[TBL] [Abstract][Full Text] [Related]
17. Quantum dots finally come of age.
Jovin TM
Nat Biotechnol; 2003 Jan; 21(1):32-3. PubMed ID: 12511905
[No Abstract] [Full Text] [Related]
18. Dynamic imaging of cell-substrate contacts.
Bhatt AK; Huttenlocher A
Methods Enzymol; 2003; 361():337-52. PubMed ID: 12624919
[No Abstract] [Full Text] [Related]
19. Imaging mitochondrial function in intact cells.
Duchen MR; Surin A; Jacobson J
Methods Enzymol; 2003; 361():353-89. PubMed ID: 12624920
[No Abstract] [Full Text] [Related]
20. Quantum dots hold promise for early cancer imaging and detection.
Pericleous P; Gazouli M; Lyberopoulou A; Rizos S; Nikiteas N; Efstathopoulos EP
Int J Cancer; 2012 Aug; 131(3):519-28. PubMed ID: 22411309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
